Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06380322 · ClinicalTrials.gov registry record
Military Health and Nutrition Examination Study
A clinical trial of Hypertension and Type 2 Diabetes, sponsored by Pennington Biomedical Research Center.
- Recruiting
- Registry status
- 650
- Enrollment target
- 3
- Study locations
NCT06380322: Recruiting study of Hypertension and Type 2 Diabetes, sponsored by Pennington Biomedical Research Center.
NCT06380322 is a study of Hypertension and Type 2 Diabetes that is actively recruiting participants, run by Pennington Biomedical Research Center. The registered enrollment target is 650 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (81% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06380322, a study of Hypertension and Type 2 Diabetes, is actively recruiting participants, sponsored by Pennington Biomedical Research Center.
- RECRUITING
- Registry status
- 650 participants
- Enrollment target
- 3
- Study locations
Study Summary
The Military Health and Nutrition Examination Study (MHANES) is a Department of Defense funded study conducted by Pennington Biomedical Research Center and the US Army Research Institute of Environmental Medicine. This cross-sectional study will assess, in a large, diverse sample of Army Service Members (n=600), food and supplement intake, cardiovascular health, body composition, biomarkers of nutritional status, measures of health status, injury prevalence, mental wellbeing, gut microbiome composition, and physical performance outcomes. The proposed study is modeled after the National Health and Nutrition Examination Survey (NHANES) and customized for the Army population.
Primary Outcome
24-hour dietary recalls will be collected using ASA24® to measure intake of macronutrients (protein, carbohydrate, and fat) and micronutrients (vitamins and minerals).
Conditions Studied
Study Locations (3)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
- Fort Johnson - Leesville
Kentucky
- Fort Campbell - Fort Campbell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2024-08-24 |
| Est. Completion | 2026-12-01 |
What NCT06380322 shows while recruiting
NCT06380322 is an observational study that tracks outcomes without assigning an intervention. The registered 650 participants enrollment target is mid-sized for trials with a published cap, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (81% lower).
The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 0 interventions.
NCT06380322 reports a single indexed study location in Louisiana, Kentucky.
Frequently Asked Questions
What is clinical trial NCT06380322 about?
NCT06380322 is a clinical study titled "Military Health and Nutrition Examination Study". The Military Health and Nutrition Examination Study (MHANES) is a Department of Defense funded study conducted by Pennington Biomedical Research Center and the US Army Research Institute of Environmental Medicine. This cross-sectional study will assess, in a large, diverse sample of Army Service Mem...
What is the current status of trial NCT06380322?
This trial is currently recruiting. The enrollment target is 650 participants. The study started on 2024-08-24. Estimated completion is 2026-12-01.
What conditions does trial NCT06380322 study?
This clinical trial studies the following conditions: Hypertension, Type 2 Diabetes, Cardiovascular Diseases, Dyslipidemias.
Who is sponsoring clinical trial NCT06380322?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06380322 being conducted?
This trial has 3 study locations across Kentucky, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06380322's enrollment target sits among peer trials
650 96th of 470 higher than 375 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
RECRUITING
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Childhood-Onset Essential Hypertension Natural History Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02934477 · 650 participants
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- NCT04579120 · 650 participants
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- NCT04875702 · 650 participants · Phase 4
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
- NCT05046600 · 650 participants
Registry of Arthrex Hand and Wrist Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI